Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019

SELL
$37.8 - $42.69 $649,706 - $733,755
-17,188 Closed
0 $0
Q3 2018

Nov 07, 2018

SELL
$39.75 - $42.69 $621,332 - $667,287
-15,631 Reduced 47.63%
17,188 $690,000
Q2 2018

Aug 01, 2018

SELL
$39.61 - $42.76 $190,999 - $206,188
-4,822 Reduced 12.81%
32,819 $1.32 Million
Q1 2018

Apr 30, 2018

BUY
$36.18 - $40.15 $100,146 - $111,135
2,768 Added 7.94%
37,641 $1.47 Million
Q4 2017

Feb 02, 2018

SELL
$35.34 - $41.9 $90,470 - $107,264
-2,560 Reduced 6.84%
34,873 $1.24 Million
Q3 2017

Nov 02, 2017

BUY
$39.44 - $41.55 $1.48 Million - $1.56 Million
37,433
37,433 $1.52 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.1B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Forward Management, LLC Portfolio

Follow Forward Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forward Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forward Management, LLC with notifications on news.